HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis.

Abstract
A retrospective study of 48 patients was conducted to evaluate the efficacy of plasma exchange in children with idiopathic rapidly progressive glomerulonephritis (IRPGN), and renal or non-renal vasculitis. All patients were followed up at a single centre over a 15 year period. Treatment consisted of corticosteroids and/or cytotoxic agents. Plasma exchange was used in all patients because of severe renal involvement and/or clinical deterioration. One hundred per cent of patients with renal vasculitis who started plasma exchange within one month of disease onset and 58% of cases with IRPGN had significant improvement in renal function. No relapses of vasculitis were observed after treatment with plasma exchange in patients with renal and non-renal vasculitis. The results suggest that plasma exchange associated with immunosuppressive treatment could be of benefit in cases of IRPGN or vasculitis in terms of both renal and extrarenal recovery.
AuthorsA Gianviti, R S Trompeter, T M Barratt, M F Lythgoe, M J Dillon
JournalArchives of disease in childhood (Arch Dis Child) Vol. 75 Issue 3 Pg. 186-90 (Sep 1996) ISSN: 1468-2044 [Electronic] England
PMID8976654 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Biopsy
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Glomerulonephritis (complications, pathology, therapy)
  • Granulomatosis with Polyangiitis (complications, therapy)
  • Humans
  • IgA Vasculitis (complications, therapy)
  • Infant
  • Lupus Erythematosus, Systemic (complications, therapy)
  • Male
  • Plasma Exchange
  • Polyarteritis Nodosa (complications, therapy)
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome
  • Vasculitis (complications, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: